Identifica't
Grups
Investigadors/es
Resultats
FEDERICO
PULIDO ORTEGA
Profesor asociado de Ciencias de la Salud
University of Texas Southwestern Medical Center
Dallas, Estados Unidos
Estàs en
col·laboracions
University of Texas Southwestern Medical Center
Publicacions en col·laboració amb investigadors/es de University of Texas Southwestern Medical Center (1)
2019
Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1
Antiviral Research, Vol. 170
Contacta
Avís legal
Ajuda
translate
ca
arrow_drop_down
translate
ca
arrow_drop_down
es
eu
gl
en
fr
de